Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 23 citing articles:

Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis
Roberta Messina, Eva‐Maria Huessler, Francesca Puledda, et al.
Cephalalgia (2023) Vol. 43, Iss. 3
Open Access | Times Cited: 76
Role of ATP in migraine mechanisms: focus on P2X3 receptors
Rashid Giniatullin, Andrea Nistri
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Effect of anti‐CGRP‐targeted therapy on migraine aura: Results of an observational case series study
Elena Cresta, Alessia Bellotti, Giovanni Rinaldi, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 5
New Oral Drugs for Migraine
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2022) Vol. 36, Iss. 9, pp. 933-949
Open Access | Times Cited: 19
Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists
Marta Waliszewska‐Prosół, Bianca Raffaelli, Marcin Straburzyński, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1039-1051
Closed Access | Times Cited: 4
Exploring the role of ubiquitination modifications in migraine headaches
Qian Zhu, Jin Yang, Lei Shi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cholecystokinin in the central and peripheral nervous system
Tomas Hökfelt, Swapnali Barde, Wen Zhong, et al.
Elsevier eBooks (2025), pp. 101-160
Closed Access
What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
Marta Waliszewska‐Prosół, Doğa Vurallı, Paolo Martelletti
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Bipartite Activation of Sensory Neurons by a TRPA1 Agonist Allyl Isothiocyanate Is Reflected by Complex Ca2+ Influx and CGRP Release Patterns: Enhancement by NGF and Inhibition with VAMP and SNAP-25 Cleaving Botulinum Neurotoxins
Mariia Belinskaia, Jiafu Wang, Seshu Kumar Kaza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1338-1338
Open Access | Times Cited: 7
Expression of the Calcitonin Receptor-like Receptor (CALCRL) in Normal and Neoplastic Tissues
Benjamin Wende, Anna-Sophia Liselott Beyer, Niklas Ruhnke, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3960-3960
Open Access | Times Cited: 6
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
Massimo Filippi, Roberta Messina, Marta Bartezaghi, et al.
Journal of Neurology (2023) Vol. 270, Iss. 11, pp. 5600-5612
Open Access | Times Cited: 5
Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Calcitonin gene‑related peptide alleviates hyperoxia‑induced human alveolar cell injury via the CGRPR/TRPV1/Ca2+ axis
Junhui Li, Hanxing Wan, Lihong Wu, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
A Comprehensive Review of the Mechanism, Efficacy, Safety, and Tolerability of Ubrogepant in the Treatment of Migraine
Ibrahim M Dighriri, Shahad Nazel, Aeshah M Alharthi, et al.
Cureus (2023)
Open Access | Times Cited: 2
Potential mechanisms for osteopathic manipulative treatment to alleviate migraine-like pain in female rats
Katherine Byrd, Makayla Lund, Yan Pan, et al.
Frontiers in Pain Research (2024) Vol. 5
Open Access
Neurophysiological and Vascular Mechanisms of Action of Serotoninergic Drugs for Abortive Migraine Treatment
Alexey Y. Sokolov, I. B. Skiba, O. A. Lyubashina
Neuroscience and Behavioral Physiology (2024) Vol. 54, Iss. 5, pp. 707-725
Closed Access
Complementary and supplementary procedures in the treatment of headache
Charly Gaul, Laura Zaranek, Gudrun Goßrau
Der Schmerz (2023) Vol. 37, Iss. 6, pp. 448-460
Closed Access | Times Cited: 1
Antibody-Based Biotherapeutics in Migraine
Willebrordus P. J. van Oosterhout
Pharmaceutical biotechnology (2024), pp. 663-672
Closed Access
The therapeutic potential of galanin in the management of pain – a review article
Tomas Hökfelt, Zsuzsanna Wiesenfeld‐Hallin
Danish Medical Journal (2024) Vol. 71, Iss. 2, pp. 1-11
Open Access
Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup Analysis
Mohamed E. Haseeb, Hazem E. Mohammed, Hatem Yaser, et al.
Research Square (Research Square) (2024)
Open Access
Research Progress of Emerging Therapeutic Drugs in the Acute Onset Period of Migraine
红 祁
Advances in Clinical Medicine (2023) Vol. 13, Iss. 05, pp. 7700-7706
Closed Access
Neurophysiological and Vascular Mechanisms of Action of the Serotoninergic Drugs for Abortive Migraine Treatment
Alexey Y. Sokolov, I. B. Skiba, O. A. Lyubashina
Успехи физиологических наук (2023) Vol. 54, Iss. 3, pp. 53-76
Closed Access
Page 1

Scroll to top